Despite advances in sanitation and immunization, vaccine-preventable diseases remain a significant cause of morbidity and mortality worldwide. In high-income countries such as the United States, coverage rates for vaccination against childhood infections remains high. However, the phenomenon of vaccine hesitancy makes maintenance of herd immunity difficult, impeding global disease eradication efforts.
Introduction
in data collection methods and data quality. 29 A few states have published county-level exemption data, 64 which have been used to study child vaccination trends in California, [30] [31] [32] Michigan, 9 Washington, 8 65 Colorado, 33 ,and others. 34 Surveys have also been conducted to explore the drivers of vaccine hesitancy; 66 however, these studies are typically small-scale and insufficient in-depth exploration of the factors 67 associated with vaccination behavior. 35, 36 The lack of verified tools for assessing and quantifying vaccine 68 underutilization prohibits the development of geographically-targeted and context-specific 69 interventions. 37 However, electronic health records offer new opportunities to study vaccination behavior 70 using high-volume and high-resolution data with greater clinical accuracy and confirmation. 38 A limited 71 number of studies have considered the use of ICD-9 codes for assessing vaccination status using claims 72 data from the CDC's Vaccine Safety Datalink (VSD) 39, 40 and Kaiser Permanente managed care 73 organization 41 ; however, these studies have been small in scale. 74 In this study, we leverage fine-grain vaccine underutilization data from a high-coverage medical 75 claims database and combine it with a hierarchical Bayesian modeling approach to estimate local 76 pockets of vaccine underutilization across the United States for the years 2012-2015. We also conduct an 77 ecological analysis of the socio-economic determinants of vaccine underutilization by focusing specifically 78 on vaccine refusal behavior (the rejection of vaccination by choice) versus underimmunization (due to 79 vaccine ineligibility, unavailability or cost). A reliable spatial and temporal understanding of vaccine 80 underutilization, based on both behavioral data and an understanding of the underlying drivers of 81 behavior, could play a critical role in clinical practice and public health decision making.
82

Results
83
We develop a two-level spatial hierarchical Bayesian model to estimate the geographic distribution of 84 vaccine underutilization. Vaccine underutilization is informed by our high-coverage U.S. claims data on 85 cases of vaccine refusal or of underimmunization, as identified by healthcare providers during patient 86 visits. Our model proceeds in two levels: first, we account for imperfect detection of vaccine 87 underutilization cases through medical claims due to spatial variation in healthcare access and insurance 88 rates. Then, based on our spatial estimates of probabilities of detection, we can infer the true abundance 89 and geographic distribution of cases. The model thus allows us to carry out surveillance of vaccine Model Fit. The model estimates tend closely to the observed data. Figure 1 shows the model 94 estimates compared to the observed data for each of three outcome measures. The Pearson 95 cross-correlation between the model estimated incidence and the incidence of observed data were 96 R=0.997 (95% CI:0.997-0.997), R=0.986 (95%CI: 0.985-0.987), and R=0.996 (95%CI: 0.996-0.997), for 97 the model outcomes of vaccine refusal, history of underimmunization, and the combined data, Predictors of vaccine underutilization and detection. We modeled the two different processes 105 leading to vaccine underutilization (vaccine refusal and underimmunization) separately, to study the 106 determinants of each process ( Figure 4 ). We found that vaccine refusal is positively associated with 107 adult education level and religious adherence, corroborating previous studies. 42, 43 We also found that 108 underimmunization is positively associated with income inequality and negatively associated with 109 percent of population living in the same area one year prior (a measure of continuity of care). 44,45 110 However, state laws, state health expenditure, population density, and average family size were not 111 significantly predictive of vaccine refusal or underimmunization, contrary to past studies. 11,18,20,30,34 112 Our method also allows us to understand determinants of the measurement of a vaccine underutilization 113 case. We found that access to healthcare (measured through availability of pediatricians) and reporting 114 5/21 California, R = 0.17 (p = 0.055) for Texas, and R = 0.40 (p = 0.041) for New Mexico. resolution and coverage. Our study illustrates the potential of big data to aid in surveillance of vaccine 131 uptake in the United States and study the social determinants of vaccine hesitancy and 132 underimmunization.
133
Our results help disentangle the process of under-immunization from the process of vaccine refusal. 134
Our observation that underimmunization is positively associated with income inequality suggests that 135 underimmunization may be associated with factors that affect healthcare access. We also observed a 136 negative association between underimmunization and the percent of the population living in the same 137 county one year prior, which may also indicate that continuity of health care plays a significant role in 138 underimmunization. In contrast, we found vaccine hesitancy to be significantly positively associated 139 with the proportion of children attending private schools and rate of religious adherence in the county. 140
These findings suggest may indicate that personal beliefs and choice drive vaccine refusal, while 141 healthcare access and continuity drive underimmunization.
142
Consideration must be taking to avoid ecological fallacy when interpreting our results. We conduct 143 statistical inference at the county-level, and we therefore are not trying to infer individual factors but 144 rather ecological ones. Previous investigations of disease. distributions has demonstrated sensitivity of 145 statistical inference to spatial scale. 46 We acknowledge that our medical claims data are not by three-digit ZIP code ( Figure S1 ). We allocated all ZIP code data to US counties using the databases for county or state-level quantifiable measures of these potential drivers. We selected predictor 171 measures initially based on the quality and spatial resolution of available data. We also assessed 172 pairwise correlation and variance inflation factors in order to minimize multi-collinearity before arriving 173
at the final set of predictor measures ( Supplemental Table S2 ). We assumed that there was minimal 174 year-to-year variability in these predictors over the four year period of study and thus obtained one set 175 of spatial data for each predictor to represent the entire study period. All predictor data was centered 176
and standardized for use in the model.
177
Predictors of database detection probability. In order to account for variability in measurement 178 bias in our medical claims data, we identified four conditions that would all have to be met in order for 179 an instance of vaccine hesitancy to be captured by our database: 1) seek pediatric health care from a 180 provider 2) be insured; 3) provider use of the claims database 4) the provider reports the vaccine refusal 181 or underimmunization case. Following exploratory analysis and assessing multi-collinearity, we selected 182 four measurement factors representing each of these measurement mechanisms for inclusion in our model 183 (Supplemental TableS1). All predictor data was centered and standardized for use in the model. As we 184
anticipated year-to-year variability in the measurement factors over the four years of our study, we 185 collected four sets of spatial data for each variable in order to account for temporal changes. the processes that describe the probability of observing vaccine underutilization in our data from those 191 that explain the true, latent prevalence of vaccine underutilization in the community. We make a 192 simplifying assumption that the latent prevalence of vaccine underutilization is constant over the 193 duration of our study period, and that our yearly counts of vaccine refusal and underimmunization 194 represent independent replicates of that latent state.
195
Thus, we modeled three outcomes: the total number of claims submitted to our medical claims 196 database for children under five years of age for 1) vaccine refusal, 2) history of underimmunization, and 197
3) summation of vaccine refusal and history of underimmunization. For each U.S. county, we assume 198 there exists a latent, true number of instances of cases, and each year in the study period presents an 199 independent opportunity to observe this true state. 200 We modeled the observed counts of vaccine underutilization (y it ) in county i in year t with a 201 binomial distribution:
where there is a probability p it of observing vaccine underutilization in the medical claims among N i 203 instances in the community (Equation 1 ). We modeled the probability of observing vaccine 204 underutilization:
where measurement process predictor W it is modulated by the estimated coefficient γ, and ν pc,i , 206 ν py,t , and ν pcy,i,t are the group effects for county, year, and county-year, respectively (Equation 2).
207
In the second level of the hierarchy, we model the latent instances of vaccine underutilization N i :
where the negative binomial distribution is parametrized by probability Q i and size r (Equation 3 ). 209
The mean of N i , µ i is defined:
and it can be separated into the expected number of cases E i , which we calculate by multiplying the 211 country-wide average rate of vaccine under-utilization according to our observed claims data by the 4). Finally, the relative risk θ i is modeled by:
where a single predictor of underutilization X i is modulated by the estimated coefficient β for all m 215 predictors, and ν µc,i and ν µs,i are county-level and state-level group effects, respectively (Equation 5). 216
Priors and hyperpriors for all β, γ, r, and random effects are shown in Supplemental in order to assess model fit.
223
Validation Results validation was performed by comparing our model estimates to county-level data 224 from annual school vaccine assessments reports on the rates of vaccine exemptions for Kindergarteners. 225 We selected states for validation based on the quality and availability of their county-level vaccine 226 exemption data. Due to state differences in the quality and collection methods of vaccine exemption 227 data, we validated our results separately for each selected state.
228
Supplemental Information
Predictor data of Detection Probability
In Table S1 , we list the predictors used to predict detection probabilities. These predictors vary annually and spatially (by county). To control for variation in physician reporting practices, we compared use of low birth weight ICD-9 codes (subcodes of V21.3, 765.0, and 765.1) in our claims data with county-level birth weight data obtained from the CDC National Vital Statistics system. 
Predictor data of Vaccine hesitancy/underimmunization
In Table S2 , we list the predictors used for the vaccine refusal or under-immunization process. Unstructured year random effects on p i,t ν pcy,i,t Unstructured county-year random effects on p i,t i, t county, year, indicators, respectively σ µc standard deviation of random effect ν µ,i σ µs standard deviation of random effect ν µ,i σ pc standard deviation of random effect ν µ,i σ py standard deviation of random effect ν py,t σ pcy standard deviation of random effect ν pcy,i,t Description of data, y i,t : county(i)/year(t)-level counts of patient claims for history of under-immunization for the year. Table S4 . Priors and Hyperpriors.
Priors: β, γ ∼ N ormal(0, 1/100) r ∼ unif orm(0, 50) ν µc,i ∼ N ormal(0, 1/σ 2 µc ) ν µs,i ∼ N ormal(0, 1/σ 2 µs ) ν pc,i ∼ N ormal(0, 1/σ 2 pc ) ν py,t ∼ N ormal(0, 1/σ 2 py ) ν pcy,i,t ∼ N ormal(0, 1/σ 2 pcy ) Hyperpriors: σ µc , σ µs ∼ unif orm(0, 3) σ pc , σ py , σ pcy ∼ unif orm(0.01, 0.99) We initialized parameter coefficients β and γ using each with a random draw from a uniform distribution from -1 to 1. Standard deviation hyperpriors for the group-level effects and r were initialized each with a random draw from a uniform distribution 0 to 1, and 1 to 20, respectively. N i was initialized for each i county as the maximum observation, y i,t over t years, plus a random draw from the Poisson distribution with mean 10. Figure S1 . Database physician coverage, 2015. Percent of AMA licensed physicians reporting to our medical claims database by three-digit zip-code and adjusted for estimated visit capture (our database does not always capture 100% of a physician's visits). Our claims database additionally includes reporting from other healthcare providers (nurses, physicians assistants, etc.); however, in order to compare representation to the AMA universe, only AMA physicians are shown here. 
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